Pernille K. Bjerre Trent

  • MD
  • +47 22 93 47 91

After graduating with honors from Jagiellonian University, Krakow, Poland, Dr Bjerre Trent returned to Norway for her internship at Ringerike Hospital and Rennesøy county. She subsequently initiated training in obstetrics and gynecology at Tønsberg and Bærum Hospitals, completing her residency at Oslo University Hospital in 2019.

Dr Bjerre Trent currently holds a position as research fellow in the Department of Gynecologic Oncology, Norwegian Radiumhospital, Oslo University Hospital. She is enrolled in the PhD-program at the University of Oslo and divides her time 50/50 between clinical duties and research. Dr. Bjerre Trent’s research focus is endometrial cancer, specifically oncologic outcomes, quality of life and health system cost after implementation of sentinel lymph node biopsy in intermediate- and high-risk endometrial cancer in the SENSOR-project.

Dr. Bjerre Trent is a member of several national and international societies, and was recently elected the Norwegian national representative to the European Network of Young Gynecologic Oncologists (ENYGO).

 

Publications 2024

Bjerre Trent PK, Nordskar NJ, Wangen KR, Engeskaug MI, Opheim MLØ, Aune G, Staff AC, Thorsen L, Falk RS, Eriksson AGZ (2024)
Corrigendum to "Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study" [Gynecologic Oncology 175 (2023) 72-80]
Gynecol Oncol, 183, 7-8 (in press)
DOI 10.1016/j.ygyno.2024.02.026, PubMed 38484693

Publications 2023

Bilir E, Ahmed W, Kacperczyk-Bartnik J, Nasser S, Bjerre Trent P, Boria F, Tsibulak I, Chacon E, Martinelli F, Strojna AN, Morgan G, Bizzarri N, Eriksson AG, Theofanakis C (2023)
Social media ambassadors and collaboration with OncoAlert: a European Network of Young Gynae Oncologists study of comparative Twitter analysis of #ESGO2021 and #ESGO2022
Int J Gynecol Cancer, 33 (6), 964-970
DOI 10.1136/ijgc-2023-004371, PubMed 37130625

Bjerre Trent P, Falk RS, Staff AC, Jorde D, Eriksson AG (2023)
Translation and cross-cultural adaptation of the Gynecologic Cancer Lymphedema Questionnaire and the Lower Extremity Lymphedema Screening Questionnaire
Int J Gynecol Cancer, 33 (2), 231-235
DOI 10.1136/ijgc-2022-003979, PubMed 36600491

Bjerre Trent PK, Nordskar NJ, Wangen KR, Engeskaug MI, Opheim MLØ, Aune G, Staff AC, Thorsen L, Falk RS, Eriksson AGZ (2023)
Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study
Gynecol Oncol, 175, 72-80
DOI 10.1016/j.ygyno.2023.05.070, PubMed 37327542

Opheim LØ, Engeskaug I, Bjerre Trent PK, Thorsen L, Staff AC, Nordskar NJ, Utne I, Hagen M, Eriksson AGZ (2023)
Associations between modifiable lifestyle factors and health-related quality of life among endometrial carcinoma survivors - A cross-sectional study
Gynecol Oncol, 179, 52-62
DOI 10.1016/j.ygyno.2023.10.012, PubMed 37924595

Publications 2022

Brunetti M, Panagopoulos I, Vitelli V, Andersen K, Hveem TS, Davidson B, Eriksson AGZ, Trent PKB, Heim S, Micci F (2022)
Endometrial Carcinoma: Molecular Cytogenetics and Transcriptomic Profile
Cancers (Basel), 14 (14)
DOI 10.3390/cancers14143536, PubMed 35884597

Publications 2021

Eriksson AGZ, Davidson B, Bjerre Trent P, Eyjólfsdóttir B, Dahl GF, Wang Y, Staff AC (2021)
Update on Sentinel Lymph Node Biopsy in Surgical Staging of Endometrial Carcinoma
J Clin Med, 10 (14)
DOI 10.3390/jcm10143094, PubMed 34300260

Page visits: 2375
Scroll to top